Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. J. Martsevich"'
Autor:
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 4, Iss 3, Pp 39-44 (2016)
Aim. To study clinical equivalence of original (DilatrendR, ≪Hoffmann-La Roche≫, Switzerland) and of generic (VedicardolR, ≪Synthesis≫, Russia) carvedilols with estimation of their serum level. And to study pharmacoeconomic advantages of thei
Externí odkaz:
https://doaj.org/article/619afb5878ea428db84a02d8784767d3
Autor:
N. P. Kutishenko, S. J. Martsevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 5, Pp 79-82 (2015)
Data of multicenter clinical trials on assessment of angiotensin converting enzyme inhibitor, lisinopril efficacy in therapy of patients with arterial hypertension, heart failure, myocardial infarction complicated with left ventricle dysfunction and
Externí odkaz:
https://doaj.org/article/0faa9da90dc341be82ef7b9a25f50ecb
Autor:
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 5, Pp 39-44 (2015)
Aim. To study clinical equivalence of two amlodipines under the control of their plasma levels and evaluate their pharmacoeconomical efficacy in patients with arterial hypertension (AH).Material and methods. 31 patient with AH were included in the st
Externí odkaz:
https://doaj.org/article/24f18ba1123e446d96cee9b234ef54c4
Autor:
S. J. Martsevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 6, Iss 4, Pp 607-609 (2016)
The ACC/AHA clopidogrel clinical alert about the possibility of ineffective treatment with clopidogrel is discussed. The reason of this resistance to clopidogrel therapy and possible ways to overcome it is considered.
Externí odkaz:
https://doaj.org/article/e9604b1f6cb443e1bd3520bedd16fb4f
Autor:
S. N. Tolpygina, D. F. Guranda, E. I. Bambysheva, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 4, Iss 3, Pp 39-44 (2016)
Aim. To study clinical equivalence of original (DilatrendR, ≪Hoffmann-La Roche≫, Switzerland) and of generic (VedicardolR, ≪Synthesis≫, Russia) carvedilols with estimation of their serum level. And to study pharmacoeconomic advantages of thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88f5d7d45285874c28494d882fdb387
https://www.rpcardio.com/jour/article/view/1111
https://www.rpcardio.com/jour/article/view/1111